BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29525556)

  • 1. Neurite orientation dispersion and density imaging of the nigrostriatal pathway in Parkinson's disease: Retrograde degeneration observed by tract-profile analysis.
    Andica C; Kamagata K; Hatano T; Okuzumi A; Saito A; Nakazawa M; Ueda R; Motoi Y; Kamiya K; Suzuki M; Hori M; Kumamaru KK; Hattori N; Aoki S
    Parkinsonism Relat Disord; 2018 Jun; 51():55-60. PubMed ID: 29525556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurite orientation dispersion and density imaging in the substantia nigra in idiopathic Parkinson disease.
    Kamagata K; Hatano T; Okuzumi A; Motoi Y; Abe O; Shimoji K; Kamiya K; Suzuki M; Hori M; Kumamaru KK; Hattori N; Aoki S
    Eur Radiol; 2016 Aug; 26(8):2567-77. PubMed ID: 26515546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.
    Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K
    Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease.
    Theisen F; Leda R; Pozorski V; Oh JM; Adluru N; Wong R; Okonkwo O; Dean DC; Bendlin BB; Johnson SC; Alexander AL; Gallagher CL
    Neuroimage Clin; 2017; 16():557-563. PubMed ID: 28971007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion tensor imaging of the nigrostriatal fibers in Parkinson's disease.
    Zhang Y; Wu IW; Buckley S; Coffey CS; Foster E; Mendick S; Seibyl J; Schuff N
    Mov Disord; 2015 Aug; 30(9):1229-36. PubMed ID: 25920732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurite orientation dispersion and density imaging (NODDI) and free-water imaging in Parkinsonism.
    Mitchell T; Archer DB; Chu WT; Coombes SA; Lai S; Wilkes BJ; McFarland NR; Okun MS; Black ML; Herschel E; Simuni T; Comella C; Xie T; Li H; Parrish TB; Kurani AS; Corcos DM; Vaillancourt DE
    Hum Brain Mapp; 2019 Dec; 40(17):5094-5107. PubMed ID: 31403737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of neurite orientation dispersion and density imaging to characterize brain microstructural abnormalities in type-2 diabetics with mild cognitive impairment.
    Xiong Y; Zhang S; Shi J; Fan Y; Zhang Q; Zhu W
    J Magn Reson Imaging; 2019 Sep; 50(3):889-898. PubMed ID: 30779402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deterministic Tractography of the Nigrostriatal-Nigropallidal Pathway in Parkinson's Disease.
    Tan WQ; Yeoh CS; Rumpel H; Nadkarni N; Lye WK; Tan EK; Chan LL
    Sci Rep; 2015 Dec; 5():17283. PubMed ID: 26619969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of neurite orientation dispersion and density imaging in ischemic stroke.
    Wang Z; Zhang S; Liu C; Yao Y; Shi J; Zhang J; Qin Y; Zhu W
    Magn Reson Imaging; 2019 Apr; 57():28-33. PubMed ID: 30385381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of neurite orientation dispersion and density imaging or diffusion tensor imaging to quantify the severity of cervical spondylotic myelopathy and to assess postoperative neurologic recovery.
    Okita G; Ohba T; Takamura T; Ebata S; Ueda R; Onishi H; Haro H; Hori M
    Spine J; 2018 Feb; 18(2):268-275. PubMed ID: 28711563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring therapeutic effects in Parkinson's disease by serial imaging of the nigrostriatal dopaminergic pathway.
    Booij J; Berendse HW
    J Neurol Sci; 2011 Nov; 310(1-2):40-3. PubMed ID: 21840542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axonal degeneration in Parkinson's disease - Basal ganglia circuitry and D2 receptor availability.
    Pelzer EA; Melzer C; Schönberger A; Hess M; Timmermann L; Eggers C; Tittgemeyer M
    Neuroimage Clin; 2019; 23():101906. PubMed ID: 31254937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of neurite orientation dispersion and density imaging in wilson's disease.
    Song YK; Li XB; Huang XL; Zhao J; Zhou XX; Wang YL; Yan X; Wang JY; Chu JP
    J Magn Reson Imaging; 2018 Aug; 48(2):423-430. PubMed ID: 29251804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-resolution diffusion tensor-imaging indicates asymmetric microstructural disorganization within substantia nigra in early Parkinson's disease.
    Knossalla F; Kohl Z; Winkler J; Schwab S; Schenk T; Engelhorn T; Doerfler A; Gölitz P
    J Clin Neurosci; 2018 Apr; 50():199-202. PubMed ID: 29366621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson Disease: Diffusion MR Imaging to Detect Nigrostriatal Pathway Loss in a Marmoset Model Treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Hikishima K; Ando K; Yano R; Kawai K; Komaki Y; Inoue T; Itoh T; Yamada M; Momoshima S; Okano HJ; Okano H
    Radiology; 2015 May; 275(2):430-7. PubMed ID: 25602507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of Diffusion Kurtosis and Neurite Density Measures in Deep Grey Matter and White Matter in Parkinson's Disease.
    Surova Y; Lampinen B; Nilsson M; Lätt J; Hall S; Widner H; ; van Westen D; Hansson O
    PLoS One; 2016; 11(6):e0157755. PubMed ID: 27362763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local white matter abnormalities in Parkinson's disease with mild cognitive impairment: Assessed with neurite orientation dispersion and density imaging.
    Zhang C; Yuan Y; Sang T; Yu L; Yu Y; Liu X; Zhou W; Zeng Q; Wang J; Peng G; Feng Y
    J Neurosci Res; 2023 Jul; 101(7):1154-1169. PubMed ID: 36854050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of diffusion tensor imaging measures of nigrostriatal neurons in macaques.
    Shimony JS; Rutlin J; Karimi M; Tian L; Snyder AZ; Loftin SK; Norris SA; Perlmutter JS
    PLoS One; 2018; 13(9):e0202201. PubMed ID: 30183721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axonal Tract Reconstruction Using a Tissue-Engineered Nigrostriatal Pathway in a Rat Model of Parkinson's Disease.
    Struzyna LA; Browne KD; Burrell JC; Vélez WJG; Wofford KL; Kaplan HM; Murthy NS; Chen HI; Duda JE; España RA; Cullen DK
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6-hydroxydopamine-induced Parkinson's disease-like degeneration generates acute microgliosis and astrogliosis in the nigrostriatal system but no bioluminescence imaging-detectable alteration in adult neurogenesis.
    Fricke IB; Viel T; Worlitzer MM; Collmann FM; Vrachimis A; Faust A; Wachsmuth L; Faber C; Dollé F; Kuhlmann MT; Schäfers K; Hermann S; Schwamborn JC; Jacobs AH
    Eur J Neurosci; 2016 May; 43(10):1352-65. PubMed ID: 26950181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.